A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers.
Morancho B, Parra-Palau JL, Ibrahim YH, Bernadó Morales C, Peg V, Bech-Serra JJ, Pandiella A, Canals F, Baselga J, Rubio I, Arribas J.
Morancho B, et al. Among authors: peg v.
Oncogene. 2013 Mar 14;32(11):1452-9. doi: 10.1038/onc.2012.152. Epub 2012 May 28.
Oncogene. 2013.
PMID: 22641219